Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.

Abstract

PURPOSE To report on the development of visually significant maculopathy associated with blood-brain barrier disruption (BBBD) therapy for the treatment of central nervous system (CNS) lymphoma. DESIGN Retrospective case series. METHODS Chart review of 20 patients undergoing BBBD therapy for treatment of CNS lymphoma at the Cleveland Clinic. Patients… (More)

Topics

Cite this paper

@article{Galor2007MaculopathyAA, title={Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.}, author={Anat Galor and Sandra J Ference and Arun Singh and Michael Sangyeob Lee and Glen H. J. Stevens and V{\'i}ctor L. P{\'e}rez and David M. Peereboom}, journal={American journal of ophthalmology}, year={2007}, volume={144 1}, pages={45-49} }